Prosecution Insights
Last updated: October 04, 2026

Armstrong Teasdale LLP (15060)

Technology area: Biotechnology & Pharmaceuticals

113 pending office actions • 26 clients • 102 examiners • 67 art units • 1 of 113 (1%) have an AI response strategy ready

Quality Metrics (n=1975 apps, methodology: how we score firms)

89.8%
Allowance Rate
n=1975
+0.62σ
Allowance Rate (norm)
n=1975
3.9
OAs to Allowance
n=1058
+0.18σ
OAs to Allow (norm)
n=1058
1132 days
Time to Allowance
n=1058
+2.3pp
Interview Lift
n=1975
39.0%
RCE Rate
n=1975
0.9%
Appeal Rate
n=1975

Rejection Performance (% of received rejections ultimately overcome)

61.5%
§101 Overcome
n=200
74.4%
§102 Overcome
n=550
76.4%
§103 Overcome
n=870
73.7%
§112 Overcome
n=567

Specialization & Scale

H02K, H02P, A61K
Top CPC Subclasses
16%
Top-3 CPC Share
n=1975
0
Practitioners
n=1975
—
Apps / Practitioner
n=1975 (min 20)

Portfolio Summary

113
Total Pending OAs
60
Non-Final OAs
41
Final Rejections
12
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 31 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

18
Overdue
0
Due this week
8
Due this month
4
Due in next 60 days
1
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 31 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (18)Due ≤ 30 days (8)Due ≤ 60 days (4)Due later (1)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

54
Hard (48%)
43
Medium (38%)
16
Easy (14%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§101 only1 (1%)
§101 + other18 (16%)
§103 only32 (28%)
§102 only5 (4%)
§112 only15 (13%)
Double-patenting only1 (1%)
Double-patenting + other6 (5%)
Multi-statute (no §101)35 (31%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

45
Life Sciences
40% of docket
3
Information Tech
3% of docket
8
Communications
7% of docket
6
Semiconductors
5% of docket
31
Mechanical / Eng
27% of docket
20
Business / Other
18% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

1,130 h
Manual time on pending OAs
226 h
Time saved (low, 20%)
396 h
Time saved (mid, 35%)
9.9 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
GORDON, MATHEW FRANKLIN 2 72.5% +12.1%
HARTMANN, ERIN MARIE 2 75.0% +37.8%
MEMON, OWAIS IQBAL 2 77.6% +14.7%
EL SAYAH, MOHAMAD O 2 75.3% +3.6%
JORGENSEN, ABBY A 2 74.0% +14.1%
KAPUSHOC, STEPHEN THOMAS 2 46.5% +53.5%
TATGE, LEXUS MARC 2 50.0% +100.0%
BROUGHTON, SHAWN CURTIS 2 44.0% +32.0%
SMITH, EMILIE ALINE 2 49.4% +35.4%
NGUYEN, QUANG 2 38.0% +52.6%

Hard Cases (54)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
17699053 GENOME SEQUENCING AS AN ALTERNATIVE TO CYTOGENETIC ANALYSIS SMITH, EMILIE ALINE 169d overdue
18143153 METHODS, MOBILE APPARATUS, AND ELECTRONIC DEVICE FOR CONTROLLING VEHICLE, COMPUTER PROGRAM, AND STORAGE MEDIUM HARTMANN, ERIN MARIE 121d overdue
18523284 HETEROARYL PYRIDONE AND AZA-PYRIDONE COMPOUNDS SHIAO, REI TSANG 91d overdue
18051488 Association Of T Cell Leukemia/Lymphoma Protein 1A (TCL1A) With Clonal Hematopoiesis Of Indeterminate Potential (CHIP) KAPUSHOC, STEPHEN THOMAS 73d overdue
18818523 METHODS OF DETECTING ONCOGENIC FUSIONS AND USES THEREOF LEITH, NANCY J 43d overdue
17628497 PARTICLE-BASED METHOD FOR DEFINING A GUT MICROBIOTA IN HUMANS OR OTHER ANIMAL SPECIES JONES, DAMERON LEVEST 36d overdue
18855529 SYSTEMS AND METHODS FOR EXTRACTING CLINICAL PHENOTYPES FOR ALZHEIMER DISEASE DEMENTIA FROM UNSTRUCTURED CLINICAL RECORDS USING NATURAL LANGUAGE PROCESSING LAGOY, KYRA RAND 11d overdue
18941026 SYSTEMS AND METHODS FOR ONGOING MULTIFACTOR AUTHENTICATION GADALLA, HANY S 21d

Interview Candidates (18)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
17699053 GENOME SEQUENCING AS AN ALTERNATIVE TO CYTOGENETIC ANALYSIS SMITH, EMILIE ALINE 169d overdue
18143153 METHODS, MOBILE APPARATUS, AND ELECTRONIC DEVICE FOR CONTROLLING VEHICLE, COMPUTER PROGRAM, AND STORAGE MEDIUM HARTMANN, ERIN MARIE 121d overdue
18711371 Conveyor Belt Module JORGENSEN, ABBY A 107d overdue
18051488 Association Of T Cell Leukemia/Lymphoma Protein 1A (TCL1A) With Clonal Hematopoiesis Of Indeterminate Potential (CHIP) KAPUSHOC, STEPHEN THOMAS 73d overdue
18456193 MICRONEEDLE-INTEGRATED INTERSTITIAL FLUID BIOMARKER SENSOR SYSTEMS AND METHODS THEREOF BROUGHTON, SHAWN CURTIS 15d overdue
18156184 Oncolytic Vaccinia Virus NGUYEN, QUANG 20d
18244577 Treatment Of Endometriosis With R-Spondin 3 (RSPO3) Inhibitors TATGE, LEXUS MARC 22d
19234911 SYSTEMS AND METHODS OF DETERMINING CHANGES IN POSE OF AN AUTONOMOUS VEHICLE GORDON, MATHEW FRANKLIN —

Client Portfolio (26 clients)

Top Art Units

Art UnitApps
16375
37914
37983
36643
36513
16833
36653
28372
26632
36582

Pending Office Actions

App #TitleClientExaminerArt UnitStatutesStatusDue inAIFiled
19358923 ULTRASOUND SENSING AND IMAGING BASED ON WHISPERING-GALLERY-MODE (WGM) MICRORESONATORS Washington University DAVIS, AMELIE R 3798 §112Other Non-Final OA — Pending Oct 15, 2025
19234911 SYSTEMS AND METHODS OF DETERMINING CHANGES IN POSE OF AN AUTONOMOUS VEHICLE Torc Robotics, Inc. GORDON, MATHEW FRANKLIN §103 Non-Final OA — Pending Jun 11, 2025
19234937 SYSTEMS AND METHODS OF DETERMINING CHANGES IN POSE OF AN AUTONOMOUS VEHICLE Torc Robotics, Inc. GORDON, MATHEW FRANKLIN §102§103 Non-Final OA — Pending Jun 11, 2025
19178775 METHOD AND ARCHITECTURE IN SUPPORT OF PATIENT-CENTRIC NETWORKS Cable Television Laboratories, Inc. KAZI, SAYEEM MUHAMMAD 2455 §103Other Non-Final OA — Pending Apr 14, 2025
19170154 CATALYST AND METHOD FOR CONVERTING CO2 TO SOLID CARBON, AND COMPOSITES INCLUDING SOLID CARBON Washington University TADAYYON ESLAMI, TABASSOM 1718 §102§103§112 Final Rejection — Pending Apr 04, 2025
19028550 BIOMEDICAL PATCHES WITH SPATIALLY ARRANGED FIBERS Washington University SALVATORE, LYNDA 1789 DP Final Rejection — Pending Jan 17, 2025
18980157 SYSTEMS AND METHODS FOR AUTOMATED ELECTROCARDIOGRAM (ECG) INTERPRETATION OF WIDE COMPLEX RHYTHMS Washington University ADAMS, WILLIAM PATRICK §101§102§103§112Other Non-Final OA — Pending Dec 13, 2024
18975694 SYSTEMS AND METHODS FOR REMOTE PROCTORING Idemia Identity & Security Usa LLC ROBINSON, AKIBA KANELLE 3626 §101§103 Non-Final OA — Pending Dec 10, 2024
18965741 VARIABLE TORQUE CONSTANT ELECTRIC MACHINES HAVING A RADIAL SPOKED ROTOR WITH AXIAL FLUX MAGNET PLATES AND METHODS THEREOF Regal Beloit Australia Pty Ltd. TRUONG, THOMAS §103 Non-Final OA — Pending Dec 02, 2024
18948046 SYSTEMS AND METHODS FOR INFRASTRUCTURE AND EVENT REPORTING FROM AUTONOMOUS FLEET Torc Robotics, Inc. HARTMANN, ERIN MARIE 3664 §103§112 Final Rejection — Pending Nov 14, 2024
18941026 SYSTEMS AND METHODS FOR ONGOING MULTIFACTOR AUTHENTICATION Cable Television Laboratories, Inc. GADALLA, HANY S 2493 §102§103 Final Rejection 21d Pending Nov 08, 2024
18935787 CONTROLLER AND DRIVE CIRCUIT FOR ELECTRIC MOTORS Regal Beloit America, Inc. BOUZIANE, SAID 2837 §102§112 Non-Final OA — Pending Nov 04, 2024
18935775 CONTROLLER AND DRIVE CIRCUIT FOR ELECTRIC MOTORS Regal Beloit America, Inc. IMTIAZ, ZOHEB S 2837 §103 Non-Final OA — Pending Nov 04, 2024
18927484 SYSTEMS AND METHODS FOR FEATURE ALIGNMENT WITH UNCERTAINTY-GUIDED REGIONAL ATTENTION FOR MULTIMODAL FUSION IN AN AUTONOMOUS VEHICLE Torc Robotics, Inc. MEMON, OWAIS IQBAL 2663 §102§103 Non-Final OA — Pending Oct 25, 2024
18855529 SYSTEMS AND METHODS FOR EXTRACTING CLINICAL PHENOTYPES FOR ALZHEIMER DISEASE DEMENTIA FROM UNSTRUCTURED CLINICAL RECORDS USING NATURAL LANGUAGE PROCESSING Washington University LAGOY, KYRA RAND 3685 §101§103§112 Non-Final OA 11d overdue Pending Oct 09, 2024
18902283 SYSTEM AND METHOD FOR 3D OBJECT DETECTION BY AN AUTONOMOUS VEHICLE IN ADVERSE ENVIRONMENTAL CONDITIONS USING MULTIMODAL FUSION Torc Robotics, Inc. SIMPSON, LIXI CHOW 2625 §102§103 Non-Final OA — Pending Sep 30, 2024
18892172 SINGLE, SUPPORT ARMATURE CAMERA TOWER INCLUDING POSITIONAL ADJUSTMENT ASSEMBLIES Idemia Identity & Security Usa LLC RHODES, JR, LEON W 2852 §102 Non-Final OA — Pending Sep 20, 2024
18882470 SYSTEMS AND METHODS FOR VIRTUAL AUTONOMOUS VEHICLE DEMONSTRATION Torc Robotics, Inc. DOSHER, JULIE GRACE 3715 §103§112 Non-Final OA — Pending Sep 11, 2024
18817828 TREATMENT OF BREAST CANCER USING COMBINATION THERAPIES COMPRISING AN ATP COMPETITIVE AKT INHIBITOR, A CDK4/6 INHIBITOR, AND FULVESTRANT Genentech, Inc. KOSTURKO, GEORGE W §102§103DP Non-Final OA — Pending Aug 28, 2024
18818523 METHODS OF DETECTING ONCOGENIC FUSIONS AND USES THEREOF Washington University LEITH, NANCY J 1681 §103§112 Non-Final OA 43d overdue Pending Aug 28, 2024
18812459 Normalization and Calibration for Devices and Systems for Measuring Peripheral Hemodynamics Washington University HENSON, DEVIN B §101§102§103 Non-Final OA — Pending Aug 22, 2024
18809439 SOLID DISPERSIONS CONTAINING AN APOPTOSIS-INDUCING AGENT AbbVie Inc. WILSON, JERICA KATLYNN §101§103Other Non-Final OA — Pending Aug 20, 2024
18837721 SYSTEMS AND METHODS OF CORRECTING MOTION IN IMAGES FOR RADIATION PLANNING Washington University BEKELE, MEKONEN T §103 Final Rejection — Pending Aug 12, 2024
18798198 Treatment Of Hyperglycemia With Solute Carrier Family 39 Member 5 (SLC39A5) Inhibitors Regeneron Pharmaceuticals, Inc. KONOPKA, CATHERINE ANNE 1635 §103§112DP Non-Final OA — Pending Aug 08, 2024
18786335 METHODOLOGY TO CHARACTERIZE EMPTY-FULL RATIO IN CRUDE AAV SAMPLES Regeneron Pharmaceuticals, Inc. GILL, RACHEL B §102§103§112 Non-Final OA — Pending Jul 26, 2024
18780463 Single Implantable Fiber Device for 2D Dynamic and Reconfigurable Light Emission and Collection Washington University GREEN, TAJANAE NICOLE §102§103 Non-Final OA — Pending Jul 22, 2024
18728807 BIFIDOBACTERIUM INFANTIS FORMULATIONS International Centre For Diarrhoeal Disease Research, Bangladesh GRASER, JENNIFER E 1645 §101§102§103§112 Non-Final OA — Pending Jul 12, 2024
18767454 STALL MARGIN IMPROVEMENT OF ROTOR FAN FOR A VANEAXIAL BLOWER SYSTEM Regal Beloit America, Inc. GOLIK, ARTHUR PAUL 3745 §103§112 Non-Final OA — Pending Jul 09, 2024
18725901 Disc Brake for a Hoist, Combining a Positive Brake and a Negative Brake Stromag France SAS RODRIGUEZ, PAMELA 3616 §103 Non-Final OA — Pending Jul 01, 2024
18743546 MODELING TRANSIENT SCENE RESPONSE USING A LIDAR WAVEFRONT SIMULATION ENVIRONMENT Torc Robotics, Inc. ADE, OGER GARCIA §103 Non-Final OA — Pending Jun 14, 2024
18733249 SYSTEM AND METHOD FOR COOLING VEHICLE AUTONOMY COMPUTING SYSTEM Torc Robotics, Inc. RUBY, TRAVIS C 2835 §102§103 Non-Final OA — Pending Jun 04, 2024
18715862 Method, Conveyor and Conveying System for Transporting Products Rexnord Flattop Europe B.V. DEUBLE, MARK A 3651 §102Other Final Rejection 56d Pending Jun 03, 2024
18731197 SYSTEMS AND METHODS FOR COOLING OPERATING PLATFORMS OF AUTONOMOUS VEHICLES Torc Robotics, Inc. EL SAYAH, MOHAMAD O 3658 §103 Non-Final OA 33d Pending May 31, 2024
18680907 POWER NETWORK SYSTEMS AND METHODS FOR DETECTING COMPONENT ERROR Torc Robotics, Inc. NGUYEN, TAN QUANG §102§103 Non-Final OA — Pending May 31, 2024
18712491 SYSTEMS AND METHODS FOR WIRELESS POWER RESONATORS WITH OPEN CORE Tc1 LLC SOLOMON, JOSHUA BRENDON §103 Non-Final OA — Pending May 22, 2024
18712368 COMPOSITIONS AND METHODS FOR TISSUE REPAIR Acatechol, Inc. BOATENG, AFUA BAMFOAA 1617 §102§103§112 Non-Final OA — Pending May 22, 2024
18669169 POSITIONABLE HOSES Torc Robotics, Inc. BURGOS-GUNTIN, NELSON R §102 Non-Final OA — Pending May 20, 2024
18711384 Conveyor Belt Module Rexnord Flattop Europe B.V. JORGENSEN, ABBY A 3651 §102§112Other Final Rejection — Pending May 17, 2024
18711371 Conveyor Belt Module Rexnord Flattop Europe B.V. JORGENSEN, ABBY A 3651 §102Other Final Rejection 107d overdue Pending May 17, 2024
18652430 CLAMPING DEVICE Tc1 LLC VAUGHAN, JASON L 3726 §102§103 Final Rejection — Pending May 01, 2024
18646961 SEPARATORS HAVING OPPOSITELY-CHARGED REGIONS AND SECONDARY BATTERIES INCLUDING THE SAME Washington University MEKHLIN, ELI S §102§103§112 Non-Final OA — Pending Apr 26, 2024
18631784 SYSTEMS, METHODS, AND PROGRAM PRODUCTS FOR PROVIDING DRIVER-SPECIFIC INFORMATION TO DRIVERS Torc Robotics, Inc. COCHRAN, BRIANNA RENAE 2615 §103 Final Rejection — Pending Apr 10, 2024
18698664 CYCLOPENTYLPYRAZOLE CDK2 INHIBITORS Genentech, Inc. MARTIN, KEVIN STEPHEN 1624 §102§103 Final Rejection — Pending Apr 04, 2024
18614287 SAFETY DECOMPOSITION USING REDUNDANT FIELD OF VIEW OF MULTIPLE SENSORS Torc Robotics, Inc. MEMON, OWAIS IQBAL 2663 §102 Non-Final OA — Pending Mar 22, 2024
18606302 Proteomic Risk Score For Osteoarthritis (OA) Regeneron Pharmaceuticals, Inc. FRITCHMAN, REBECCA M §101§103§112 Non-Final OA — Pending Mar 15, 2024
18582159 Treatment Of Obesity In Subjects Having Variant Nucleic Acid Molecules Encoding Calcitonin Receptor (CALCR) Regeneron Pharmaceuticals, Inc. KAPUSHOC, STEPHEN THOMAS 1683 §112DP Non-Final OA — Pending Feb 20, 2024
18428273 Assays For Determining Severity Of Peanut Allergies Allergenis, Inc. NGUYEN, BAO THUY L §101§103§112DP Non-Final OA — Pending Jan 31, 2024
18416578 SYSTEMS AND METHODS FOR ATTENUATION COMPENSATION IN SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT) Washington University SORRIN, AARON JOSEPH 2672 §112 Non-Final OA — Pending Jan 18, 2024
18410132 AUTONOMOUS VEHICLE RESPONSES TO TRAILER FIRES Torc Robotics, Inc. SHARMA, NABIN KUMAR 3612 §103 Final Rejection — Pending Jan 11, 2024
18408897 DELIVERY SYSTEM AND METHOD FOR MIDDLE-MILE CARGO DELIVERY USING UNMANNED AERIAL VEHICLES Torc Robotics, Inc. IVEY, DANA DESHAWN 3662 §103 Final Rejection — Pending Jan 10, 2024
18409617 OPTICAL CAMERA BASED AND MACHINE LEARNING TRAINED FLAT TIRE DETECTION Torc Robotics, Inc. MEHDIZADEH, NAVID Z 3669 §103 Final Rejection — Pending Jan 10, 2024
18407951 SYSTEMS AND METHODS FOR SIGNALING INTENT FOR AN AUTONOMOUS VEHICLE Torc Robotics, Inc. HUYNH, CHRISTINE NGUYEN 3662 §103 Final Rejection 22d Pending Jan 09, 2024
18398639 SYSTEMS AND METHODS FOR DETECTING AND SUPPRESSING VEHICLE TRAILER FIRES Torc Robotics, Inc. KIM, CHRISTOPHER S 3752 §112 Final Rejection — Pending Dec 28, 2023
18398655 SYSTEMS AND METHODS FOR DETECTING AND SUPPRESSING VEHICLE TRAILER FIRES Torc Robotics, Inc. BOECKMANN, JASON J 3752 §103 Final Rejection 26d overdue Pending Dec 28, 2023
18545110 SYSTEMS AND METHODS FOR AUTOMATIC THREE-DIMENSIONAL OBJECT DETECTION AND ANNOTATION Torc Robotics, Inc. CRUZ, IRIANA 2681 §103§112 Non-Final OA — Pending Dec 19, 2023
18544236 METHODS OF TREATING CANCER USING B-RAF INHIBITORS AND IMMUNE CHECKPOINT INHIBITORS Genentech, Inc. RODRIGUEZ, RAYNA B 1628 §103 Final Rejection — Pending Dec 18, 2023
18535052 Treatment Of Type 2 Diabetes With Hepatocyte Nuclear Factor 4 Alpha (HNF4A) Agonists Regeneron Pharmaceuticals, Inc. PERSONS, JENNA L 4100 §112 Non-Final OA — Pending Dec 11, 2023
18535105 Treatment Of Prion Diseases Regeneron Pharmaceuticals, Inc. ZARA, JANE J 4100 §103§112 Non-Final OA — Pending Dec 11, 2023
18528268 METHODS TO CHARACTERIZING A FRAGMENT CRYSTALLIZABLE DOMAIN OF A BISPECIFIC ANTIBODY Regeneron Pharmaceuticals, Inc. RAMADAN, OMAR 1678 §102§103§112 Non-Final OA — Pending Dec 04, 2023
18523284 HETEROARYL PYRIDONE AND AZA-PYRIDONE COMPOUNDS Genentech, Inc. SHIAO, REI TSANG 1691 §103§112 Non-Final OA 91d overdue AI Ready Nov 29, 2023
18510900 Treatment Of Inflammation With Glucocorticoids And Angiopoietin-Like 7 (ANGPTL7) Inhibitors Regeneron Pharmaceuticals, Inc. HUDSON, AMY ROSE 1636 §103§112DP Non-Final OA — Pending Nov 16, 2023
18559932 USE OF SOS1 INHIBITORS WITH MTOR INHIBITORS TO TREAT CANCERS Revolution Medicines, Inc. BAUER, NICOLA MARIA 1621 §103§112 Non-Final OA — Pending Nov 09, 2023
18289181 Peptides And Methods For Detecting Egg Allergies Icahn School Of Medicine AT Mount Sinai JOHANSEN, PETER N. 1644 §101§102§103§112 Non-Final OA — Pending Nov 01, 2023
18488316 HSD17B13 VARIANTS AND USES THEREOF Regeneron Pharmaceuticals, Inc. ZAHORIK, AMANDA MARY 1636 §112 Non-Final OA — Pending Oct 17, 2023
18552936 RECHARGEABLE ANODE-FREE SODIUM METAL BATTERIES ENABLED BY NON-POROUS SODIUM METAL PLATING AND STRIPPING Washington University SHEIKH, HAROON S 1751 §112 Non-Final OA — Pending Sep 28, 2023
18370829 ASSOCIATING DETECTED OBJECTS AND TRAFFIC LANES USING COMPUTER VISION Torc Robotics, Inc. LE, VU 2668 §103 Non-Final OA 22d Pending Sep 20, 2023
18466073 ELECTROLYZER Washington University JACOBSON, SARAH JORDAN 1785 §102§103 Final Rejection — Pending Sep 13, 2023
18244577 Treatment Of Endometriosis With R-Spondin 3 (RSPO3) Inhibitors Regeneron Pharmaceuticals, Inc. TATGE, LEXUS MARC 1637 §101§112 Final Rejection 22d Pending Sep 11, 2023
18548755 TRANSCUTANEOUS AURICULAR VAGAL NERVE STIMULATION FOR SUBARACHNOID HEMORRHAGES Washington University STOKLOSA, JOSEPH A 3700 §103 Final Rejection — Pending Sep 01, 2023
18456193 MICRONEEDLE-INTEGRATED INTERSTITIAL FLUID BIOMARKER SENSOR SYSTEMS AND METHODS THEREOF General Electric Company BROUGHTON, SHAWN CURTIS 3791 §103 Non-Final OA 15d overdue Pending Aug 25, 2023
18456146 WEARABLE DEVICE FOR ON-DEMAND INTERSTITIAL FLUID BIOMARKER SENSING WITH A MICRONEEDLE-INTEGRATED SENSOR General Electric Company BROUGHTON, SHAWN CURTIS 3791 §112 Non-Final OA — Pending Aug 25, 2023
18278707 MICROBIAL PRODUCTION OF POLYMERIC AMYLOID FIBERS Washington University JOHNSON, TIRONE DEREK 1675 §102§103§112 Non-Final OA — Pending Aug 24, 2023
18234101 Methods Of Associating Genetic Variants With A Clinical Outcome In Patients Suffering From Age-Related Macular Degeneration Treated With Anti-VEGF Regeneron Pharmaceuticals, Inc. KRIANGCHAIVECH, KETTIP 1672 §101§112 Non-Final OA — Pending Aug 15, 2023
18355108 Macrophage Stimulating 1 Receptor (MST1R) Variants And Uses Thereof Regeneron Pharmaceuticals, Inc. SCHWECHTER, BRANDON ROSS 1674 §112 Final Rejection 34d Pending Jul 19, 2023
18260354 ADJUSTABLE SEAL FOR FLUID MANAGEMENT SYSTEM Washington University STUART, COLIN W 3791 §102§103§112 Non-Final OA — Pending Jul 05, 2023
18342499 WORLD MODEL GENERATION AND CORRECTION FOR AUTONOMOUS VEHICLES Torc Robotics, Inc. PEKO, BRITTANY RENEE 3665 §103 Final Rejection 17d overdue Pending Jun 27, 2023
18268276 SYSTEMS AND METHODS FOR HEAT MANAGEMENT IN WIRELESS POWER TRANSFER SYSTEMS Tc1 LLC NORRIS, JEREMY C 1735 §103 Non-Final OA — Pending Jun 19, 2023
18036695 MICROBIAL PRODUCTION OF TITIN FIBERS WITH EXCEPTIONAL MECHANICAL PERFORMANCE Washington University TSAY, MARSHA M 1656 §101§102 Non-Final OA 21d Pending May 12, 2023
18143153 METHODS, MOBILE APPARATUS, AND ELECTRONIC DEVICE FOR CONTROLLING VEHICLE, COMPUTER PROGRAM, AND STORAGE MEDIUM Idemia Identity & Security Usa LLC HARTMANN, ERIN MARIE 3664 §103§112 Final Rejection 121d overdue Pending May 04, 2023
18311338 SYSTEMS AND METHODS FOR EVALUATION AND PREDICTION OF RISK OF MALIGNANT EDEMA AFTER STROKE Washington University BEGEMAN, ANDREW W 3798 §101§103§112 Non-Final OA — Pending May 03, 2023
18311620 SYSTEMS AND METHODS OF AUTOMATICALLY DETECTING IMPROPER VEHICLE ROAD BEHAVIOR Torc Robotics, Inc. ZHAO, CHRISTINE NMN 2677 §103 Non-Final OA — Pending May 03, 2023
18306737 Transcriptome Analysis For Treating Inflammation Regeneron Pharmaceuticals, Inc. SMITH, EMILIE ALINE 1686 §103§112 Non-Final OA — Pending Apr 25, 2023
18302956 POSITION DETERMINATION VIA ENCODED INDICATORS IN A PHYSICAL ENVIRONMENT Torc Robotics, Inc. HEFLIN, HARRISON JAMES RIEL 3665 §103 Final Rejection 4d overdue Pending Apr 19, 2023
18302520 ANIMAL COLLISION AWARE PLANNING SYSTEMS AND METHODS FOR AUTONOMOUS VEHICLES Torc Robotics, Inc. HORNER, MINATO LEE 3665 §103 Final Rejection 18d overdue Pending Apr 18, 2023
18300269 KIT FOR BYPASSING A COMPRESSOR OR FAN Regal Beloit America, Inc. LAUGHLIN, CHARLES S 2846 §103 Final Rejection — Pending Apr 13, 2023
18192522 AUTONOMOUS DRIVING SIMULATOR Torc Robotics, Inc. PIERRE LOUIS, ANDRE §103 Non-Final OA — Pending Mar 29, 2023
18192504 AUTONOMOUS DRIVING SIMULATOR Torc Robotics, Inc. WANG, KAI NMN 3664 §103 Non-Final OA 32d overdue Pending Mar 29, 2023
18184446 SYSTEMS AND METHODS FOR A POINT-TO-POINT DRIVER MESSENGER FOR ADVANCED COOPERATIVE SITUATIONAL AWARENESS Honda Motor Co., Ltd. EL SAYAH, MOHAMAD O 3658 §103 Final Rejection 55d Pending Mar 15, 2023
18168853 Threshold Assays For Cumulative Reactive Doses Of Peanut Antigens Allergenis LLC GABEL, GAILENE 1678 §103§112Other Non-Final OA — Pending Feb 14, 2023
18159265 PYRROLIDINONES HERBICIDES Fmc Corporation SCHLIENTZ, NATHAN W 1616 §103 Final Rejection — Pending Jan 25, 2023
18157587 Methods Of Improving Health With Apolipoprotein E (APOE) Inhibitors Regeneron Pharmaceuticals, Inc. CASH, KAILEY ELIZABETH 1683 §102§103DP Non-Final OA 32d overdue Pending Jan 20, 2023
18156184 Oncolytic Vaccinia Virus Queen Mary University Of London NGUYEN, QUANG 1631 §112 Final Rejection 20d Pending Jan 18, 2023
18152346 Triggering Receptor Expressed On Myeloid Cells 2 (TREM2) Variants And Uses Thereof Regeneron Pharmaceuticals, Inc. SALMON, KATHERINE D 1682 §102§103§112 Non-Final OA — Pending Jan 10, 2023
18079358 Dosage Unit Formulations Of Autologous Dermal Fibroblasts Castle Creek Biosciences, LLC VIVLEMORE, TRACY ANN 1638 §101§103§112 Final Rejection — Pending Dec 12, 2022
18059719 Treatment Of Lung Disease Based Upon Stratification Of Polygenic Score Relating To Response To A Therapeutic Agent Regeneron Pharmaceuticals, Inc. GODDARD, LAURA B 1642 §101§103§112 Non-Final OA — Pending Nov 29, 2022
18057298 Methods Of Treating Headaches And Migraines With Sodium Voltage-Gated Channel Alpha Subunit 11 (SCN11A) Inhibitors Regeneron Pharmaceuticals, Inc. TATGE, LEXUS MARC 1637 §101§112 Final Rejection — Pending Nov 21, 2022
18051488 Association Of T Cell Leukemia/Lymphoma Protein 1A (TCL1A) With Clonal Hematopoiesis Of Indeterminate Potential (CHIP) Regeneron Pharmaceuticals, Inc. KAPUSHOC, STEPHEN THOMAS 1683 §103§112 Non-Final OA 73d overdue Pending Oct 31, 2022
17936715 Treatment Of Psychiatric Disorders And Psychiatric Disorder-Associated MRI Phenotypes With Stabilin 1 (STAB1) Inhibitors Regeneron Pharmaceuticals, Inc. ANGELL, JON E 1637 §112 Final Rejection 13d Pending Sep 29, 2022
17934277 Methods Of Treating Chronic Kidney Disease (CKD) With Inhibitors Of Protective Loss-Of-Function Genes Regeneron Pharmaceuticals, Inc. KENYON, JOHN S 1625 §112 Non-Final OA 49d overdue Pending Sep 22, 2022
17821806 Treatment Of Inflammatory Diseases With RAS Protein Activator Like 3 (RASAL3) Inhibitors Regeneron Pharmaceuticals, Inc. VYAS, KEYUR ANILKUMAR 1637 §112 Non-Final OA — Pending Aug 24, 2022
17809713 SYSTEMS AND METHODS FOR TRAINING ENERGY-EFFICIENT SPIKING GROWTH TRANSFORM NEURAL NETWORKS Washington University THAI, JASMINE THANH 2129 §103 Non-Final OA — Pending Jun 29, 2022
17735586 SYSTEMS AND METHODS OF ADAPTIVE RADIOTHERAPY WITH CONVENTIONAL LINEAR PARTICLE ACCELERATOR (LINAC) RADIOTHERAPY DEVICES Washington University VIRK, ADIL PARTAP S 3798 §103§112 Non-Final OA — Pending May 03, 2022
17699053 GENOME SEQUENCING AS AN ALTERNATIVE TO CYTOGENETIC ANALYSIS Washington University SMITH, EMILIE ALINE 1686 §101§103 Final Rejection 169d overdue Pending Mar 18, 2022
17683468 Treatment Of Liver Disease With Ring Finger Protein 213 (RNF213) Inhibitors Regeneron Pharmaceuticals, Inc. VYAS, KEYUR ANILKUMAR 1637 §112 Final Rejection — Pending Mar 01, 2022
17584642 Methods Of Improving Health With Apolipoprotein E (APOE) Inhibitors Regeneron Pharmaceuticals, Inc. SUNSHINE, HANNAH LOUISE 1647 §112Other Final Rejection — Pending Jan 26, 2022
17628497 PARTICLE-BASED METHOD FOR DEFINING A GUT MICROBIOTA IN HUMANS OR OTHER ANIMAL SPECIES Washington University JONES, DAMERON LEVEST 1618 §103§112 Non-Final OA 36d overdue Pending Jan 19, 2022
17628491 COMPOSITIONS AND METHODS TO AFFECT HUMAN GUT MICROBES Intercontinental Great Brands LLC HOFFMAN, SUSAN COE 1655 §103 Final Rejection 46d overdue Pending Jan 19, 2022
17574524 METHOD TO PERFORM SPECTRAL BIOPSY OF ELECTROPHYSIOLOGICAL BRAIN FUNCTION Washington University MORONESO, JONATHAN DREW 3791 §101§103§112 Final Rejection 28d Pending Jan 12, 2022
17618314 MICROBIOTA-DIRECTED FOODS TO REPAIR A SUBJECT'S GUT MICROBIOTA International Centre For Diarrhoeal Disease Research, Bangladesh TRAN, LIEN THUY 1793 §103 Final Rejection 24d overdue Pending Dec 10, 2021
17514396 SYSTEMS AND METHODS FOR UNCERTAINTY PREDICTION USING MACHINE LEARNING GE Grid GmbH NIMOX, RAYMOND LONDALE 2857 §101 Final Rejection — Pending Oct 29, 2021
16644650 Single Immunoglobulin Interleukin-1 Receptor Related (SIGIRR) Variants And Uses Thereof Regeneron Pharmaceuticals, Inc. SITTON, JEHANNE SOUAYA 1682 §103§112 Non-Final OA — Pending Mar 05, 2020
16737200 TREATMENT OF TYPE I AND TYPE II DIABETES Melior Pharmaceuticals I, Inc. NIEBAUER, RONALD T 1658 DPOther Final Rejection 70d Pending Jan 08, 2020
16086151 COMPOSITIONS AND METHODS FOR TREATMENT OF TYPE VII COLLAGEN DEFICIENCIES Castle Creek Biosciences, LLC NGUYEN, QUANG 1631 §112 Non-Final OA — Pending Sep 18, 2018

Managing Armstrong Teasdale LLP (15060)'s Patent Prosecution?

IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month